Yale spinout Modifi agreed to sell to Merck for $30 million upfront. Elsewhere, Sangamo plotted a much faster path to market ...

(Reuters) - Merck has acquired Modifi Biosciences for as much as $1.3 billion, gaining access to its experimental cancer ...

We recently compiled a list of the 8 Best US Stocks For Foreign Investors Right Now. In this article, we are going to take a ...

While you may think of healthcare as only covering human health, animal and pet health is also a growing sector. Click to ...

Equine Veterinary Therapeutics MarketThe global equine veterinary therapeutics market is poised for significant expansion, ...

MERGE announces new Chair. MERGE, a Chicago-based integrated technology and marketing services provider, has a new board ...

The Animal Antibacterial and Antibiotics Market is being driven by several key factors. Rising livestock production and ...

Dengue fever is a mosquito-borne viral infection that when mild, can cause flu-like symptoms. But in a more severe form, the virus can also lead to internal bleeding, organ damage, and death. For ...

A new biotechnology company called Judo Bio is taking a strike at kidney diseases, armed with $100 million and a RNA drug platform it claims can get ... said Sehgal, the Alnylam vet. One of Judo’s ...

Seemingly trying to maintain some balance in their global pricing strategies, Big Pharma companies such as Merck and BMS have avoided the drastic PD-1 drug price reductions in China’s national ...